Nagoya, Japan

Nobuyuki Itoh

This inventor holds 2 USPTO granted patents. Top assignee: Sanwa Kagaku Kenkyusho Co., Ltd.. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuyuki Itoh. Retrieved from https://idiyas.com/inventor/nobuyuki-itoh-zom2mtiv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 1996

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Nobuyuki Itoh: Innovator in Pharmaceutical Chemistry

Introduction

Nobuyuki Itoh is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Itoh's work focuses on developing new compounds with potential therapeutic applications.

Latest Patents

Itoh's latest patents include a 1-azabicyclo[3.3.0]octan derivative and benzopyrancarboxamide derivatives. The first patent describes a 1-azabicyclo[3.3.0]octan derivative, which includes a pharmacologically acceptable salt of the compound. This compound is noted for its potential use as hypermotility agents. The second patent involves benzopyrancarboxamide derivatives, which also includes a pharmacologically acceptable salt and outlines a process for their preparation and use.

Career Highlights

Nobuyuki Itoh is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he has been instrumental in advancing research in pharmaceutical compounds. His innovative approach has led to the development of new chemical entities that may have significant implications in medicine.

Collaborations

Itoh has collaborated with notable colleagues, including Yutaka Baba and Toshinao Usui. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical products.

Conclusion

Nobuyuki Itoh's contributions to pharmaceutical chemistry through his patents demonstrate his commitment to innovation in the field. His work continues to pave the way for new therapeutic agents that could benefit many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…